Increased Tyrosine Kinase Activites May Lead to the Phenotypic Differences of Gastric Cancer Cells

Anticancer Research

Volumn 24, Issue 2 B, 2004, Pages 699-705

  Ono, Hitoshi ^a   Takeuchi, Yoshiaki ^a   Ukegawa, Jun Ichi ^a   Kusayanagi, Satoshi ^a   Mitamura, Keiji ^a   Imawari, Michio ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Catenin; Cell adhesion; E cadherin; Gastric cancer

Indexed keywords

ALPHA CATENIN; BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PLAKOGLOBIN; PROTEIN TYROSINE KINASE; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOLECULAR MECHANICS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; STOMACH CARCINOMA;

CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; EPIDERMAL GROWTH FACTOR; HUMANS; PHENOTYPE; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN-TYROSINE KINASES; STOMACH NEOPLASMS;

EID: 2442613025     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microb Scand 64: 31-37, 1965.
2. Correa P: Human gastric carcinogenesis: A multistep and multifactorial process-first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 52: 6735-6740, 1992.
3. Aplin AE, Howe AK and Juliano RL: Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol 11: 737-744, 1999.
4. Farquhar MG and Palade GE: Junctional complexes in various epithelia. J Cell Biol 17: 375-412, 1963.
5. Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251: 1451-1454, 1991.
6. Vleminckx K and Kemler R: Cadherins and tissue formation: integrating adhesion and signaling. Bioessays 21: 211-220, 1999.
7. Cowin P and Burke B: Cytoskeleton-membrane interactions. Curr Opin Cell Biol 8: 56-65, 1996.
8. McNeil H, Ozawa M, Kemler R and Nelson WJ: Novel function of the cell adhesion molecule uvomorulin as an inducer of cell surface polarity. Cell 62: 309-316, 1990.
9. Mandai K, Nakanishi H, Satoh A, Takahashi K, Satoh K, Nishioka H, Mizoguchi A and Takai Y: Ponsin/SH3P12: An 1-afadin-and vinculin-binding protein localized at cell-cell and cell-matrix adherens junctions. J Cell Biol 144: 1001-1017, 1999.
10. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T and Hirohashi S: E-cadherin gene mutation in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91: 1858-1862, 1994.
11. Jawhari A, Jordan S, Poole S, Broene P, Pignatelli M and Farthing MJG: Abnormal immuoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterol 122: 46-54, 1997.
12. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Miller A and Reeve AE: E-cadherin germline mutations in familial gastric cancer. Nature 392: 402-405, 1998.
13. Nagafuchi A and Takeichi M: Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J 7: 3679-3684, 1988.
14. Behrens J, Vakaet L, Friis R, Winterhager E, Roy FV, Mareel MM and Birchmeier W: Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120: 757-766, 1993.
15. Owens DW, McLean GW, Wyke AW, Paraskeva C, Parkinson EK, Frame MC and Brunton VG: The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol Biol Cell 11: 51-64, 2000.
16. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S and Hirohashi S: Cadherin dysfunction in a human cancer cell line: possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 52: 5770-5774, 1992.
17. Motoyama T, Hojo H and Watanabe H: Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36: 65-83, 1986.
18. Sekiguchi M, Sakakibara K and Fujii G: Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48: 61-68, 1978.
19. Shibamoto S, Hayakawa M, Takeuchi K, Hori T, Oku N, Miyazawa K, Kitamura N, Takeichi M and Ito F: Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1: 295-305, 1994.
20. Potempa S and Ridley AJ: Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Biol Cell 9: 2185-2200, 1998.
21. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D and Birchmerier W: E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
22. Handschuh G, Candidus S, Luber B, Reich U, Schott C, Oswald S, Becke H, Hutzler P, Birchmeier W, Höfler H and Becker KF: Tumor-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and induce cellular motility. Oncogene 18: 4301-4312, 1999.
23. Behrens J, Löwrick O, Klein-Hitpass L and Birchmeier W: The E-cadherin promoter: Functional analysis of a GC-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci USA 88: 11495-11499, 1991.
24. Yoshimura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T and Hirohashi S: Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92: 7416-7419, 1995.
25. Li L-C, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P and Dahiya R: A single nucleotide polymorphism in the E-cadherin gene prompter alters transcriptional activities. Cancer Res 60: 873-876, 2000.
26. Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, Nagafuchi A, Tsukita S, Shibamoto S and Ito F: A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54: 6282-6287, 1994.
27. Ozawa M and Kemler R: Altered cell adhesion activity by pervanadate due to the dissociation of α-catenin from the E-cadherin-catenin complex. J Biol Chem 273: 6166-6170, 1998.
28. Shibata T, Ochiai,A, Kanai Y, Akimoto S, Gotoh M, Yasui N, Machinami R and Hirohashi S: Dominant negative inhibition of the association between β-catenin and c-erbB-2 by N-terminally deleted β-catenin suppresses the invasion and metastasis of cancer cells. Oncogene 13: 883-889, 1996.
29. Daniel JM and Reynolds AB: Tyrosine phosphorylation and cadherin/catenin function. BioEssays 19: 883-891, 1997.
30. Roura S, Miravet S, Piedra J, Garcia de Herreros A and Dunach M: Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J Biol Chem 274: 36734-36740, 1999.
31. Takeda H, Nagafuchi A, Yonemura S, Tsukita S, Behrens J, Birchmeier W and Tsukita S: V-src kinase shift the cadherin-based cell adhesion from the strong to the weak state and β catenin is not required for the shift. J Cell Biol 131: 1839-1847, 1995.
32. D'souza B and Taylor-Papadimitriou J: Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. Proc Natl Acad Sci USA 91: 7202-7206, 1994.
33. Novak A, Hsu S-C, L-H C, Radeva G, Papkoff J, Montesano R, Roskelley C, Grosschedl R and Dedher S: Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathway. Proc Natl Acad Sci USA 95: 4374-4379, 1998.
34. v-src causes tyrosine phosphorylation and inactivation of the N-cadherin cell adhesion system, EMBO J 12: 307-314, 1993.
35. Müller T, Choidas A, Reichmann E and Ullrich A: Phosphorylation and free pool of β-catenin are regulated by tyrosine kinases and tyrosine phopsphatases during epithelial cell migration. J Biol Chem 275: 10173-10183, 1999.